Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014502 |
| CAS No | NA |
| Mol.F. | C17H20N2O4 |
| Mol.Wt. | 316.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014503 |
| CAS No | NA |
| Mol.F. | C18H17F3N2O5 |
| Mol.Wt. | 398.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014504 |
| CAS No | NA |
| Mol.F. | C20H14BrN7O2 |
| Mol.Wt. | 464.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014505 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014506 |
| CAS No | NA |
| Mol.F. | C14H10F3N3O3 |
| Mol.Wt. | 325.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014507 |
| CAS No | NA |
| Mol.F. | C16H11FN4O4 |
| Mol.Wt. | 342.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014508 |
| CAS No | NA |
| Mol.F. | C23H25FN7O10P |
| Mol.Wt. | 609.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014509 |
| CAS No | NA |
| Mol.F. | C23H24FN8O11P |
| Mol.Wt. | 638.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014510 |
| CAS No | NA |
| Mol.F. | C23H25FN7O10P |
| Mol.Wt. | 609.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014511 |
| CAS No | NA |
| Mol.F. | C14H16N4O2 |
| Mol.Wt. | 272.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014512 |
| CAS No | NA |
| Mol.F. | C21H21N9O5S4 |
| Mol.Wt. | 607.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014513 |
| CAS No | NA |
| Mol.F. | C21H22N9O8PS4 |
| Mol.Wt. | 687.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014514 |
| CAS No | NA |
| Mol.F. | C22H23ClFN5O4 |
| Mol.Wt. | 475.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014515 |
| CAS No | NA |
| Mol.F. | C29H43N9O4 |
| Mol.Wt. | 581.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014516 |
| CAS No | NA |
| Mol.F. | C29H42N10O5 |
| Mol.Wt. | 610.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014517 |
| CAS No | NA |
| Mol.F. | C29H43N9O4 |
| Mol.Wt. | 581.7 |
| INV STATUS | CUSTOM SYNTHESIS |